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Abstract. Indonesia has been facing a hard time accelerating the number of laboratory capacity. This study provides an 
overview of the data on daily tests, confirmed cases, and the challenge of Covid-19 control associated with government 
policy. This study utilizes data reported from 2 March to 29 April 2020 by online official sources and regulations. 
Initially, the government only trusted one lab for the Covid-19 test. As the number of cases increased, referral labs were 
increased, until 29 April 2020, there were 89 officially appointed laboratories. The daily number of testing results 
fluctuated and unstable, although the number of reference labs increases. This reflects implementation challenges from 
different factors: readiness and capacity between labs; availability of swab collection officers; availability of reagents in 
the lab; rules for lab officers and swab collection officers; and transportation for a specimen from health facility to the 
referral lab. This study recommends to ensure the lab readiness in terms of human resources, tools, and reagents when 
appointed; ensure the adequacy and quality of qualified laboratory staff & swab collectors; ensure adequate reagents for 
RT-PCR, and rearrangement of shift rules for lab & swab collection officers, and improve handling procedures and 
transport specimen delivery mechanisms. 
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Abstrak. Indonesia kesulitan melakukan percepatan jumlah kapasitas laboratorium (Lab). Tujuan studi mereview hasil 
testing harian, kasus terkonfirmasi, dan tantangan imlementasi penanganan Covid-19 dikaitkan dengan kebijakan 
pemerintah. Analisis studi memanfaatkan data sekunder, periode 2 Maret sampai 29 April 2020, yang dilaporkan 
berbagai website resmi dan kajian regulasi. Awalnya pemerintah hanya percaya satu lab untuk testing Covid-19. 
Seiring bertambahnya kasus, jumlah lab rujukan ditambah, sampai tanggal 29 April 2020 sudah 89 lab yang ditunjuk 
resmi. Hasil testing harian memperlihatkan angka yang berfluktuasi. Ini mencerminkan tantangan implementasi dari 
berbagai faktor: kesiapan dan kapasitas antar laboratorium; ketersediaan & kemampuan petugas pengumpul swab; 
ketersediaan reagen di laboratorium; aturan untuk petugas lab dan petugas pengumpul swab; dan transportasi untuk 
spesimen dari fasilitas kesehatan ke laboratorium rujukan. Studi ini merekomendasikan untuk memastikan kesiapan 
laboratorium dalam hal sumber daya manusia, alat, dan reagen ketika ditunjuk; memastikan kecukupan dan kualitas 
petugas lab & pengambil swab mumpuni; memastikan kecukupan logistik reagen untuk RT-PCR; dan penataan ulang 
aturan shift untuk petugas lab & pengumpul swab, dan meningkatkan prosedur penanganan dan mekanisme 
transportasi pengiriman specimen. 
INTRODUCTION 
Covid-19 is a new type of disease that was first 
discovered in Wuhan, China (1). This disease spread 
quickly throughout the world. The WHO even declared 
Covid-19 as a world pandemic. At present 213 countries 
have contracted Covid-19, one of which is Indonesia  
(2). Based on publications from Wuhan's condition, the 
disease is spread by transmission through droplets 
produced by coughing, sneezing, or talking, with an 
average incubation period of about 5.2 days (3). The 
period from the onset of Covid-19 symptoms to death 
ranges from 6 to 41 days with a median of 14 days (4). 
The number of covid-19 cases reached 3.2 million 
worldwide as of April 29, 2020. The largest number of 
cases were found in the United States which reached 1 
million cases, Spain with 236 thousand cases, and Italy 
with 203 thousand cases (5). The speed of the disease 
spread and its pandemic patterns in a country can be 
done through testing. Without testing, there is no other 
way to understand this pandemic. Testing is one of the 
most important tools for determining the reduction in 
the spread and impact of the disease. With testing, it is 
possible to identify infected individuals, isolate those 
who are infected, contact tracing and quarantine, as well 
as administering infected care (6). It certainly can help 
allocate medical resources and staff more efficiently. 
The country with the highest number of testing is the 
United States. As of April 28, 2020, it reported 5.7 
million testing or an average of around 59 thousand per 
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METHODS 
 
Study Design. This study is an observational study using 
secondary data from the published Covid-19 daily case 
report and the RT-PCR tests report. The data were then 
confirmed to relevant resource persons, and policies or 
program intervention options taken by the government 
of Indonesia in response to the Covid-19 pandemic. 
Secondary data sources were obtained from 4 main data 
sources, namely worldometers.info, Covid-19.go.id, 
infectionsemerging.kemkes.go.id, and kawalCovid-
19.id. The data period was from the first detected case 
in Indonesia, which was March 2, to April 29, 2020. 
While other sources to enrich the study was from the 
government regulations, daily press conference, and 
webinar scholar discussions. The data analysis was 
carried out using statistical software and spreadsheet 
software, by looking at the magnitude and pattern of the 
data, then associated with the policy context or 
intervention choices made by the government. 
Type of Covid-19 Tests. There are two types of tests for 
COVID-19, the first of which is testing for the presence 
of antibodies, which aim to determine whether a person 
has been infected at some point in the past. The most 
common way to enforce Covid-19 cases with the Real-
Time Polymerase Chain Reaction (RT-PCR) test, 
according to WHO recommendations (8). Second, the 
serological test, generally still in the research & 
development stage, is known as a rapid test. The 
purpose of this test is to determine the extent to which 
coronavirus has spread to a wider population (9). This 
rapid test is also used in Indonesia which functions as 
screening, but confirmation of Covid-19 cases must use 
RT-PCR. In this study, the data refer to the results of 
RT-PCR testing that are announced daily by the 
government. 
 
 
RESULTS AND DISSCUSION  
 
Testing Condition in Indonesia 
The first Covid-19 case in Indonesia was found in two 
women suspected of being infected by a Japanese 
citizen living in Malaysia. This case was revealed on 
March 2, 2020. This case is the mother and daughter 
(10). The case was revealed because of the initiative of 
a patient (daughter) who reported her condition after her 
colleague proved to be positive Covid-19 after returning 
to Malaysia. Before the case was revealed, the Ministry 
of Health had examined 64 specimens from 16 
provinces, but the results were 62 negative and 2 were 
under examination (11). Meanwhile, several countries 
reported positive citizens Covid-19 after returning from 
Indonesia. Many countries doubt Indonesia's report that 
there are no cases. Indonesia has direct flights to various 
cities in China, including Wuhan (12). 
day (7). European countries have also tested millions, 
such as Russia (3.1 million), Germany (2.0 million), 
Italy (1.7 million), and Spain (1.3 million). Meanwhile, 
countries in Asia are still under 1 million testing, except 
the UAE (1 million). Other countries with a high 
number of testing include India (716 thousand), South 
Korea (608 thousand), and Iran (442 thousand) (5). 
There is no exact number to measure the effectiveness 
of how many tests must be done. However, we can 
learn from the experience of other countries regarding 
the number of testing that is considered successful 
because the number of active cases of Covid-19 has 
begun to decline, for example, South Korea. As of April 
23, 2020, South Korea had 583,971 tests, with positive 
results of 10,702 or around 1.8%. It can be learned that 
countries need a high number of testing quickly, with 
the expected result of a small portion of a positive test 
(less than 2%). The number of this testing can be used 
as a reference, when possible, to get closer to zero, like 
in Vietnam. This indicates the risk of the population 
contracting Covid-19 infection has been low. 
Table 1. Description of the number of testing, cases, testing per 
population in the ASEAN countries until April 23, 2020 
 
 
The table above shows the performance of Indonesian 
testing as measured with the ratio of the number of 
testing per 1 million population. Indonesia is the lowest 
compared to other ASEAN countries, compared to 
Vietnam and Thailand which has 3-4 times more than 
Indonesia. One thing that needs to pay attention is the 
proportion of the number of positive cases to the 
number of testing. The higher the proportion of positive 
test results, the riskier people are exposed to Covid-19 
in the region. Among ASEAN countries, Indonesia 
(14%) and Singapore (12%) had the highest proportion. 
This may indicate the real number of actual cases is 
likely to be far greater than the reported ones. 
Compared with Vietnam, the proportion of positive 
cases is only 0.1% among those tested. 
The question is, why does Indonesia face difficulties in 
accelerating as many as possible of Covid-19 tests? 
This study tries to answer this question. It aims at 
obtaining a description of daily test results, confirmed 
cases, and the challenges of implementation of the 
response to Covid-19 pandemic in relation with the 
government of Indonesia’s regulations or interventions. 
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The graph shows the slow progress of the Covid-19 test 
in Indonesia, since the announcement of the first 
Covid-19 case, March 2, 2020. The government insists 
that PCR testing is only conducted at the Ministry of 
Health's Research and Development Agency. Over time 
and the increased number of cases, then on March 15, 
2020, the government added 3 institutions designated 
as Covid-19 test referral lab (13). The results of the 
examination are then sent to MOH Litbangkes Lab, not 
directly to the hospital, which results in the hospital 
and the patient taking longer to receive the results. It 
implies longer patient's length of stay and delayed 
medical proper treatment for the patient (14). Other 
regions need to wait longer, until 8 days without the 
results. Another problem thst needs to resolve is the 
difference between the results between the local 
referral lab and MOH Lab (14). To speed up Covid-19 
testing, the Ministry of SOEs has ordered 10 PCR tools 
from one European country (15). 
The government of Indonesian finally established the 
Covid-19 pandemic as a National Disaster on March 
14, 2020 (16). To respond to this, MOH added 11 labs 
that were allowed to do the testing as of March 17, 
2020 (17). Two days later it was added to 35 labs (18). 
Eventually, the number of people tested rose sharply 
from 1898 tests (March 19) to 11,242 tests (April 5). 
Whereas previously in the same period time it could 
only reach 1898 cases. The government continues to 
increase the capacity of reference laboratories to 48 
units as of April 4, 2020. With the addition of B2 level 
laboratory capacity, starting from day 35, the increase 
in test examinations from 10 thousand to 30 thousand 
only needs 8 days. 
There are two indicators related to the test announced 
by GOI, initially, the number of new people tested. 
Furthermore, starting April 15, the number of tests that 
have been performed is also displayed, which includes 
tests for old cases or Covid-19 patients in care. If 
referring to the initial indicators, then as if the length of 
time to reach 30 thousand to 60 thousand people tested 
is 11 days. Even though the total number of tests 
carried out was 86,985 testing (19). When using the test 
number indicator, it only takes 5 days to reach 60 
thousand testings. The Ministry of Health reports the 
number of samples tested because all patients in the 
hospital need to do PCR testing again to make sure it 
has healed when discharged. So one person can have 
more than one PCR testing. As of April 29, 2020, there 
have been about 19,000 additional tests conducted for 
people with Covid-19 patients or, on average, 1 patient 
received 2 more additional PCR tests. 
Daily testing achievements 
Daily observations showed fluctuations in the number 
of testing results, starting on the 23rd day, then 
reaching a peak on the 27th day and then dropping until 
the 32nd day. The following days, starting to reach 
checks above 1000 tests per day, but still fluctuate, 
which sometimes jumps and falls sharply. The addition 
of the number of reference laboratories has not helped 
the achievement of daily testing results to be more 
stable. With this pattern, it is difficult to measure true 
capacity. The average of the last 3 days shows the daily 
capacity tested in 3 days. If the number is stable, it 
should not be far between the test results and the 
average number. 
 
Currently, there is no clear information from the 
government regarding the number of the testing 
capacity of all reference laboratories in Indonesia. The 
information conveyed by each reference laboratory is 
different in the amount of capacity. On April 29, 2020, 
the number of appointed reference laboratories was 
added to 41, bringing the total to 89 (20). It consists of 
48 laboratories in hospitals, 15 laboratories in 
universities, and 18 laboratories in the Ministry of 
Health laboratory network. Besides, there are five 
laboratories in the regional health laboratory network 
and there are three laboratories in the Directorate of 
Veterinary Laboratories. To illustrate the capacity, one 
of the designated laboratories is Eikjman, Jakarta. The 
lab has a PCR test capacity of around 180 tests per day 
and is expected to be able to conduct 1000 tests per day 
(21). 
As of March 19, 2020, there were 35 referral 
laboratories, assuming 100 tests per day were used, 
with a capacity of around 3,500 tests per day. However, 
until April 25, 2020, it was still far below the capacity 
of testing per day, except on April 7, 2020, reaching 
7,111 tests. This shows that there is still a lot of unused 
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laboratory capacity than it should (idle). Although the 
government continues to increase the number of 
laboratory capacities, the latest regulations reach 89 
reference laboratories. Various problems can be raised 
by this fact. First, no shipment of specimens must be 
examined by a laboratory, because they have not been 
sent from the health facility below. The addition of the 
number of referral laboratories has not been matched by 
the addition of officers in the field. Swab takers must 
be specially trained, which is not easy to do. For those 
who are not trained and not prepared properly, the 
number of samples examined by laboratory staff cannot 
increase linearly. Besides, sample delivery equipment 
must also be available. If there is a shortage, it will 
cause many laboratories to not be able to work by their 
capacity. These problems are indicated by fluctuations 
in the number of samples sent daily to the referral 
laboratory. 
Second, lack of reagent material in the reference 
laboratory to conduct PCR because it has not been sent 
from the center, or due to different brand between PCR 
and the reagent provided by the government (14). This 
resulted in laboratory personnel unable to work. This 
was acknowledged by a spokesman for the Covid-19 
task force, several laboratories are stopping examining 
Covid-19 patients to undergo PCR tests due to running 
out of kit or reagent devices (22). Third, not all 
laboratories appointed by the referral government were 
ready to operate. Information obtained from one of the 
informants, there were still reference laboratories that 
had not been able to do PCR testing because they had 
not been trained (23). As a result, the workload 
between reference labs varied. Fourth, governance or 
work methods that have not been standardized between 
referral laboratories and/or between teams of staff at the 
lower level. The existence of a sharp increase or 
decrease indicates a buildup of work to be done, it can 
happen in a laboratory or a health facility. If observed, 
this happens on holidays. Fifth, Indonesia's vast 
geographical location and islands. The most difficult 
challenges are related to distance, delivery time, 
availability of specimen delivery equipment, and 
specimen delivery procedures, especially for areas far 
from the reference laboratory. Transportation problem 
for transporting specimens from local health facility 
to reference/central lab, causing negative results (14). 
 
The lower the percentage of positive cases the better, 
because more and more positive cases were not found 
from the results of testing. The graph shows a sharp 
increase in the proportion of cases at the beginning of 
testing, to a peak of around 25% of the results of 
positive Covid-19 testing. This is understandable 
because cases are still small, so contact tracing from 
positive patients is still easy to do and look for. 
However, as time goes by and cases increase and 
spread, the capacity and speed of tracing cases become 
increasingly difficult. On the other hand, there is 
limited capacity of the laboratory, field staff, and the 
availability of reagents for PCR. Although the trend 
has begun to decline, a positive proportion has begun 
to stabilize at around 15%. But the real number of 
cases is certainly far greater than officially reported by 
the government. The target to be achieved is around 
2% as happened in South Korea, or Vietnam under 1%. 
At present, for the calculation of the magnitude of 
Covid-19 cases, the suspects number can be used as a 
proxy for the magnitude of Covid-19 cases in 
Indonesia, which reaches 21,827 cases. Unfortunately, 
those with PDP status cannot all be done by PCR 
because of the limitations of testing. 
Reagents are the main component for conducting RT-
PCR and are a struggle throughout the world because 
all countries want to do testing as quickly and as much 
as possible. However, the government has promised to 
bring reagents from other countries and is expected to 
arrive in waves from South Korea and China. 
According to a spokesman for the Covid-19 task force, 
"Indonesia has brought at least several reagents from 
abroad. For example, on April 16 there were 10 
thousand reagents, 19 April as many as 50 thousand 
reagents, 21 April 12,300 reagents, 23 April 15 
thousand reagents, and 24 April we hoping that we can 
receive 400 thousand (reagents) of tests" (24). If that 
promise can be fulfilled, then in the next few days 
there will be an increase in the number of tests and 
positive cases detected. Adequate treatment and 
logistical space must be prepared for treatment, 
especially ventilators. 
Efforts to Produce Own RT-PCR Test Kits 
Indonesia is highly dependent on other countries to be 
able to do RT-PCR testing. This is because PCR-based 
specimens for throat swabs are imported from other 
countries, while PCR test kits are limited in number, 
and are sought by all countries in the world. So, 
Indonesia is difficult to get the desired amount. As a 
result, the capacity of the number of tests that can be 
carried out by the government every day is low 
compared to other countries in Southeast Asia. To 
overcome this problem, researchers have developed a 
project called the Indonesian Task Force for Research 
and Technological Innovation for Handling COVID-19 
(TFRIC19). The team is coordinated by the 
Technology Assessment & Application Agency 
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(BPPT), which involves various parties including 
government elements (National Research and 
Development Agency and Eijkman Molecular 
Biological Institute), private elements (Nusantics & 
East Venture), and BUMN (Bio Farma). One of the 
outputs from the team's work was to independently 
produce Real-Time Polymerase Chain Reaction (RT-
PCR) test kits (25). 
The development of RT-PCR test kits is now entering 
the preparation stage for mass production, executed by 
a pharmaceutical SOE, Biofarma. This PCR test kit 
will be named Indonesia TFRIC19, previously named 
Nusantara TRFIC19. This test kit is expected to be able 
to be produced by Biofarma in the 3rd week of May 
2020. At present, the installed capacity at the Biofarma 
factory in Bandung is 15,000 test kits which are packed 
in 600 boxes per day (26). The plan will be produced 
as many as 100,000 units. Meanwhile, Biofarma will 
also bear the costs of the production process, while a 
distribution from the factory to the user will be assisted 
by the Indonesian movement PASTI BISA. If this can 
be realized immediately, then the limitations of the 
test-kit limitations can be overcome immediately. 
 
DISCUSSION 
The Indonesian government is facing a hard time 
accelerating PCR testing, at first, it wanted to be 
careful in testing standards so that it only appointed 
one lab. Over time and as cases increased, the number 
of Covid-19 reference labs was increased to 46 referral 
labs until 28 April 2020. Daily testing indicated a 
fluctuation of achievements per day. This may reflect 
implementation challenges from some factors: 1) 
readiness and capacity between labs; 2) availability of 
swab collection officers; 3) availability of reagents in 
the lab; 4) rules for lab officers and swab collection 
officers; 5) transportation for a specimen from health 
facility to the referral lab. In overcoming the scarcity 
of reagents, the government in collaboration with 
various parties in the country has made its PCR test 
kits. The PCR test kit is expected to have been 
produced by mid-May 2020. If that can be realized, 
then the acceleration of testing can be carried out 
immediately. 
 
RECOMMENDATIONS 
There are several suggestions based on this study, 
namely: First, ensuring that the reference labs 
designated are under standards both in terms of human 
resources, availability of tools, and reagents so that 
when appointed by the government they can 
immediately operate. Second, ensuring the additional 
adequacy of swab-taking field officers as the number 
of designated reference labs increases, especially in the 
red zone or areas that are confirmed positive for 
Covid-19. If this is not met, then the lab capacity will 
be idle. To that end, recruit officers for swab collection 
and provide adequate training. Third, the shift rules for 
the lab team in the lab and swab collectors need to be 
improved, especially working hours on holidays. The 
goal is to avoid fluctuations in daily test results so that 
actual lab capacity can be measured. Fourth, ensure 
adequate logistical PCR reagents for all referral labs. 
For this reason, a monitoring system for qualified 
logistical requests and deliveries must be made by 
using an information technology system. Also, pay 
attention to the time lag of purchasing reagents from 
the supplier so that there is no delay. Fifth, Indonesia's 
geographical location is very broad and the position of 
the reference lab may not be all easily accessible to 
certain regions. For this reason, a specimen's delivery 
and packaging procedures need to be considered. 
Sixth, encourage and strengthen the ability of existing 
resources in the country to be able to produce logistics 
needs and the needs of medical devices independently. 
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